X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216899
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-22-2023-51785.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-8-2022-1654674832.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-23-2022-1648013269.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-18-2021-1629274448.pdf
https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=329&loginreturnUrl=SSOCheckOnly
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212133
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-14-2019-1565765849.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-10-2019-1562736086.pdf
https://www.pharmacompass.com/pdf/news/pharmedium-services-llc-issues-voluntary-nationwide-recall-of-05-mgml-hydromorphone-hcl-in-09-sodium-chloride-1-ml-in-3-ml-bd-syringe-due-to-presence-of-sulfite-1562221119.pdf
https://www.pharmacompass.com/pdf/news/Spectrum-Laboratory-Products-Receives-FDA-Warning-Letter-1560408618.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-8-2019-1557294096.pdf
https://www.pharmacompass.com/pdf/news/health-canada-recalls-of-purdue-pharma-hydromorph-contin-controlled-release-capsule-24-mg-1556078906.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-27-2019-1553661457.pdf
https://www.raps.org/news-and-articles/news-articles/2018/11/fda-warns-against-using-implanted-pumps-with-unapp?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%2014%20November
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-November-7-2018-1541578996.pdf
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-July-25-2018-1532506531.pdf
https://www.reuters.com/article/us-hikma-pharma-injectables/hikma-raising-injectable-opioids-output-to-help-ease-shortage-at-u-s-hospitals-idUSKBN1K81BY
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-20-2018-1529474392.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-2-2018-1525237297.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202159
https://www.pharmacompass.com/pdf/news/premier-pharmacy-labs-issues-voluntary-nationwide-recall-of-specific-sterile-injectable-products-lots-1523508373.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-21-2018-1521610042.pdf
https://www.fiercepharma.com/manufacturing/injectable-opioids-scarce-hospitals-and-hospices-despite-u-s-being-awash-pills
https://www.pharmacompass.com/pdf/news/hospira-issues-a-voluntary-nationwide-recall-for-hydromorphone-hcl-injection-usp-cii-1520311986.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2018-1519803579.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-14-2018-1518587433.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210506
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-22-2017-1511333424.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-1-2017-1509512060.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210176
https://www.pharmacompass.com/pdf/news/SCA-Pharmaceuticals-Issues-Voluntary-Nationwide-Recall-of-Specific-Products-1508760244.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-27-2017-1506575777.pdf
http://www.prnewswire.com/news-releases/perrigo-announces-fda-final-approval-for-its-ab-rated-generic-version-of-exalgo-32mg-extended-release-tablets-300523621.html
https://www.pharmacompass.com/pdf/news/hospira-issues-voluntary-worldwide-recall-for-lots-of-hydromorphone-hcl-injection-usp-cii-2-mgml-1mgml-vial-levophed-1504322332.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-16-2017-1502850779.pdf
https://www.pharmacompass.com/pdf/news/hospira-healthcare-corporation-issues-recall-of-hydromorphone-hydrochloride-injection-usp-hp-10-1501821821.pdf
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-August-2-2017-1501649040.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2017-1496811142.pdf
http://www.in-pharmatechnologist.com/Ingredients/Lannett-injects-50m-into-Wyoming-generic-opioid-build
http://www.reuters.com/article/us-canada-drugs-exclusive-idUSKBN1570J8
http://www.einnews.com/pr_news/358075170/acura-pharmaceutical-provides-development-update-on-its-limitx-tm-technology
https://www.pharmacompass.com/pdf/news/osmoticas-generic-hydromorphone-hydrochloride-approved-in-usa-to-treat-pain-1468664983.pdf
https://www.pharmacompass.com/pdf/news/us-fda-enforcement-report-8june2016-1465388450.pdf
https://www.pharmacompass.com/pdf/news/aurolifes-generic-hydromorphone-hcl-approved-in-us-as-an-opioid-analgesic-1463569882.pdf
Market Place
Share 
